A Piggyback Attack

A Piggyback Attack Using the common cold to deliver an HIV vaccine By Kerry Grens Related Articles 5 HIV Treatment Strategies The best offense? CCR5 inhibitors, with one now on the market, suggest it may be a good defense Stem cells and gene therapy: Researchers take a second look at using stem cells to treat HIV Solving the viral spike: Can structural biology find a chink in HIV's armor? Reconstructing early HIV: The search for immun

Written byKerry Grens

| 3 min read

Save for Later

Listen with Speechify

0:00

3:00

By Kerry Grens

5 HIV Treatment Strategies

The best offense? CCR5 inhibitors, with one now on the market, suggest it may be a good defense

Stem cells and gene therapy: Researchers take a second look at using stem cells to treat HIV

Solving the viral spike: Can structural biology find a chink in HIV's armor?

Reconstructing early HIV: The search for immunogens delves into the virus' past

Profile: A Receptive Leader: Panacos' Graham Allaway

PODCAST: Andrea Gawrylewski interviews NIAID director Anthony Fauci, who gives his take on HIV research priorities.

In a bustling laboratory at the University of Pennsylvania's Wistar Institute, Hildegund Ertl, director of the Wistar's recently established Vaccine Center, stands at a centrifuge waiting for her tubes to stop spinning. At another end of the laboratory bits of mouse vaginal tract shake in jars of pink collagenase, while at a microscope a student counts fuzzy, spherical lymphocytes.

Ertl's ...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!

Join for free today

Already a member?

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Kerry Grens
Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.
View Full Profile